Authors: Jones, SE Khandelwal, P McIntyre, K Mennel, R Orr, D Kirby, R Agura, E Duncan, L Hyman, W Roque, T Regan, D Schuster, M Dimitrov, N Garrison, L Lange, M

Citation: Se. Jones et al., Randomized, double-blind, placebo-controlled trial to evaluate the hematopoietic growth factor PIXY321 after moderate-dose fluorouracil, doxorubicin,and cyclophosphamide in stage II and III breast cancer, J CL ONCOL, 17(10), 1999, pp. 3025-3032